MENA BIOLOGICS & BIOSIMILARS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, Factor VIII ( Xyntha, Octanate, Kovaltry, Advate, Koate, Adynovate, Kogenate, Hemlibra, Elocta, Recombinate, Feiba, Immunate, Alphanate, Novoeight), Erythropoietin (Epoetin Alfa (Procrit, Epogen), Darbepoietin Alfa (Aranesp), Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt)

Published In: 25 Mar, 2025
Code: CMI4393
Page number: 160
Formats: Excel and PDF
Industry: Biotechnology
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Product Type
  - Market Snippet, By Therapeutic Application
  - Market Snippet, By Region/Country
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Recent Trends
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER’s Analysis
MENA Biologics & Biosimilars Market, By Product Type, 2021–2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Influenza Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
  - Segment Trends
- Factor VIII
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
    - Xyntha
    - Octanate
    - Kovaltry
    - Advate
    - Koate
    - Adynovate
    - Kogenate
    - Hemlibra
    - Elocta
    - Recombinate
    - Feiba
    - Immunate
    - Alphanate
    - Novoeight
- Erythropoietin
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
    - Epoetin Alfa (Procrit, Epogen)
    - Darbepoietin Alfa (Aranesp)
    - Epoetin Alfa-epbx (Retacrit)
- Aflibercept (EYLEA)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- Ziv-Aflibercept (ZALTRAP)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
MENA Biologics & Biosimilars Market, By Therapeutic Application, 2021–2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Hemophilia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
  - Segment Trends
- Age-Related Macular Degeneration
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
  - Segment Trends
- Kidney Diseases
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
  - Segment Trends
- Influenza
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
  - Segment Trends
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
  - Segment Trends
MENA Biologics & Biosimilars Market, By Region/Country, 2021–2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Gulf
  - Market Size and Forecast, Y-o-Y Growth, By Product Type, 2021 –2033, (US$ Mn)
  - Market Size and Forecast, Y-o-Y Growth, By Therapeutic Application, 2021 –2033, (US$ Mn)
  - Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 –2033, (US$ Mn)
    - Saudi Arabia
    - UAE
    - Kuwait
- Egypt
  - Market Size and Forecast, Y-o-Y Growth, By Product Type, 2021 –2033, (US$ Mn)
  - Market Size and Forecast, Y-o-Y Growth, By Therapeutic Application, 2021 –2033, (US$ Mn)
Competitive Landscape
- Company Profiles
  - Pfizer, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - F. Hoffmann-La Roche Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Regeneron Pharmaceuticals Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Sanofi
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Amgen Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Analyst’s Views
Section
- References
- Research Methodology
- About us and Contact

*Browse 15 market data tables and 24 figures on “MENA Biologics & Biosimilars Market” – MENA forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now